Market Research Industry Reports

Oncolix Inc (ONCX) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Oncolix Inc (Oncolix) is a clinical stage biotechnology company. It is developing a targeted therapeutic protein, Prolanta for the treatment of ovarian, breast and other cancers. Prolanta is a recombinant analogue to the human prolactin and acts as an antagonist to the prolactin receptor. Oncolix partners with other organizations such as BioVectra, Inc and Greenville Hospital System for the further development of Prolanta. It is also a member of BIO and BioHouston. The company works with various collaborators at The University Texas MD Anderson Cancer Center and developed the efficiency data in ovarian cancer. Oncolix is headquartered in Houston, Texas, the US.

Oncolix Inc (ONCX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncolix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oncolix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Oncolix Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Oncolix Raises USD0.3 Million in Venture Financing 10
Oncolix Raises USD0.2 Million in Financing 11
Oncolix Raises USD0.15 Million in Venture Financing 12
Oncolix Raises USD4.2 Million in Series A Financing 13
Oncolix Plans To Raise Additional US$5 Million In Venture Financing 14
Oncolix Raises US$2.4 Million In Venture Financing 15
Equity Offering 16
Oncolix Files Registration Statement for Public Offering of Shares 16
Debt Offering 17
Oncolix Raises USD1.2 Million in Public Offering of 10% Notes Due 2019 17
Acquisition 18
Advanced Environmental Petroleum Producers Acquires Oncolix in Reverse Acquisition 18
Oncolix Inc - Key Competitors 19
Oncolix Inc - Key Employees 20
Oncolix Inc - Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Financial Announcements 22
Jul 24, 2018: Centene reports 2018 second quarter results and updates 2018 guidance 22
Corporate Communications 24
Jun 26, 2018: Oncolix names Wall Street Veteran, Sherry Grisewood, to Its board of directors 24
Dec 18, 2017: Oncolix Announces Approval for Listing on OTC-QB 25
Dec 05, 2017: Oncolix Announces Submission of Application for Listing on OTC-QB 26
Product News 27
12/04/2017: Oncolix Expands Board of Directors with New Appointment 27
Clinical Trials 28
Jan 31, 2018: Oncolix Sponsors Additional Research with MD Anderson Cancer Center 28
Jan 08, 2018: Oncolix Initiates Patient Recruitment of Second Cohort of Prolanta Phase 1 Trial in Advanced Ovarian Cancer 29
Nov 28, 2017: Oncolix Continues Progress as an Emerging Clinical-Stage Biopharmaceutical Company with Stock Ticker Symbol Change to ONCX 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List Of Tables


Oncolix Inc, Pharmaceuticals & Healthcare, Key Facts 2
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncolix Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncolix Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Oncolix Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Oncolix Raises USD0.3 Million in Venture Financing 10
Oncolix Raises USD0.2 Million in Financing 11
Oncolix Raises USD0.15 Million in Venture Financing 12
Oncolix Raises USD4.2 Million in Series A Financing 13
Oncolix Plans To Raise Additional US$5 Million In Venture Financing 14
Oncolix Raises US$2.4 Million In Venture Financing 15
Oncolix Files Registration Statement for Public Offering of Shares 16
Oncolix Raises USD1.2 Million in Public Offering of 10% Notes Due 2019 17
Advanced Environmental Petroleum Producers Acquires Oncolix in Reverse Acquisition 18
Oncolix Inc, Key Competitors 19
Oncolix Inc, Key Employees 20

List Of Figures


Oncolix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oncolix Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oncolix Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Oncolix Inc (ONCX) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Oncolix Inc (Oncolix) is a clinical stage biotechnology company. It is developing a targeted therapeutic protein, Prolanta for the treatment of ovarian, breast and other cancers. Prolanta is a recombinant

USD 250View Report

Oncolix Inc (ONCX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oncolix Inc (Oncolix) is a clinical stage biopharmaceutical company. It is developing a targeted therapeutic protein, Prolanta for the treatment of ovarian, breast and other cancers. Prolanta is a recombinant

USD 250View Report

Oncolix Inc (ONCX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oncolix Inc (Oncolix) is a clinical stage biopharmaceutical company. It is developing a targeted therapeutic protein, Prolanta for the treatment of ovarian, breast and other cancers. Prolanta is a recombinant

USD 250View Report

Oncolix Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Oncolix Inc (Oncolix) is a clinical stage biopharmaceutical company. It is developing a targeted therapeutic protein, Prolanta for the treatment of ovarian, breast and other cancers. Prolanta is a recombinant

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Sep 2018
No. of Pages :31
Country :United States of America
Category :Company Profiles
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube